Head to head
Novanta vs Keysight Technologies
Side-by-side on the measures that matter, with a plain-English read. Full detail: NOVT · KEYS
NOVT
Novanta
128.79-4.46%
1-year price shape — +21% over the period
Quant Rating D · 62/100
vs
KEYS
Keysight Technologies
331.21-3.18%
1-year price shape — +104% over the period
Quant Rating B · 95/100
1-year performance, rebased to 100
Keysight Technologies edges it on the scoreable measures. Keysight Technologies has the highest Quant Rating (95); Keysight Technologies has done best over the past year (+104%); Keysight Technologies trades cheapest on trailing earnings.
| NOVT | KEYS | |
|---|---|---|
| Snapshot | ||
| Sector | -- | Scientific & Technical Instruments |
| Last price | 128.79 | 331.21 |
| Change today | -4.46% | -3.18% |
| 1-year return | +20.8% | +103.9% |
| Market cap | $4.87B | $56.39B |
| 52-week range | 98.27 – 176.38 | 163.28 – 389.93 |
| Valuation | ||
| P/E (TTM) | 81.51 | 45.50 |
| P/E percentile, own 5-yr range | 77th | 89th |
| P/B | 3.01 | 8.58 |
| Dividend yield | 0.00% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | 1.47 | 4.91 |
| Net profit (TTM) | $55.59M | $835.90M |
| Revenue (TTM) | $1.03B | $6.58B |
| Revenue growth (YoY) | +10.3% | +36.5% |
| Gross margin | 44.5% | 64.7% |
| Operating margin | 11.6% | 20.3% |
| Net margin | 6.0% | 19.1% |
| Free cash flow (TTM) | $114.28M | $1.47B |
| Ownership & sentiment | ||
| Institutional ownership | 122.3% | 91.8% |
| Insider activity (12mo) | 21 buy / 29 sell | 11 buy / 37 sell |
| Short interest (% of float) | 13.6% | 1.4% |
| Analyst consensus | 100% buy (2) | 91% buy / 9% hold (11) |
| Analyst price target | $194 (+51%) | $427 (+29%) |
| StockVane view | ||
| StockVane Quant Rating | D (62) | B (95) |
| Company | ||
| Employees | 3,000 | 16,800 |
| Founded | 1968 | 1937 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.